Boehringer Ingelheim reports that Bovela, the BVD vaccine it launched in March 2015, became the market leader in terms of share of sales per month1 in July 2017.

Matt Yarnall from Boehringer Ingelheim said: "This is fantastic news for Bovela which offers a truly unique and innovative way of controlling BVD in a herd, something that is now clearly being appreciated by farmers and vets alike."

The company says over 5 million doses of Bovela have now been sold across Europe2 showing how quickly farmers have understood the benefits of a single dose vaccine that provides a full 12 months of live vaccine protection. 

Matt added: "Feedback we have from vets and farmers throughout Europe shows two main things. Firstly, for those who haven’t controlled BVD before, there is the realisation of how much better herd health can be and secondly, for those who have previously struggled with multiple primary course vaccines or those that should be boosted every six months, there is relief at Bovela’s easy-to-follow regime."

References

  1. Kynetec (2017) August BVD sales data
  2. BI data, July 2017

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.